Federal Register / Vol. 72, No.

239 / Thursday, December 13, 2007 / Notices 70873

One collection, entitled ‘‘Health and
Diet Survey—General Topics,’’ tracks a
broad range of consumer attitudes,
awareness, knowledge, and self-reported
behaviors related to key diet and health
issues. The other collection, entitled
‘‘Health and Diet Survey—Dietary
Guidelines Supplement,’’ will provide
FDA with updated information about
consumer attitudes, awareness,
knowledge, and behavior regarding
various elements of nutrition and
physical activity based on the key
recommendations of the Dietary
Guidelines for Americans, which are
jointly issued by the Department of
Health and Human Services and
Department of Agriculture every 5 years.
The information to be collected with
the Health and Diet Survey—General
Topics will include: (1) Awareness of
diet-disease relationships; (2) food and
dietary supplement label use; (3) dietary
practices including strategies to lose or
maintain weight; and (4) awareness and
knowledge of dietary fats. The
information to be collected with the
Health and Diet Survey—Dietary
Guidelines Supplement will include: (1)
Opinions about the nutrition
information provided by the
government; (2) awareness and
familiarity with government nutrition
programs and publications such as the
Food Guide Pyramid and the Dietary
Guidelines for Americans; (3)
knowledge of the relationships between
food choices, exercise habits, weight
loss, and health; (4) choices surrounding
exercise, calorie intake, saturated and
trans fats, fruits and vegetables, whole
grains, dairy, fish, meat, cholesterol,
carbohydrates, salt, and sugar. The
survey will also ask about use of Federal
nutrition information, special diet,
weight status, health status, and
demographics.
FDA and other Federal agencies will
use the information from the Health and
Diet Survey to evaluate and develop
strategies and programs to encourage
and help consumers adopt healthy
lifestyles. The information will also
help FDA and other Federal agencies
evaluate and track consumer awareness
and behavior as outcome measures of
their achievement in improving public
health.
Description of Respondents: The
respondents are adults, age 18 and
older, drawn from the 50 states and the
District of Columbia. Participation will
be voluntary.
In the Federal Register of May 25,
2007 (72 FR 29332), FDA published a
60-day notice requesting public
comment on the information collection
provisions. No comments were received.

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

No. of Annual Frequency Total Annual Hours per
Activity Total Hours
Respondents per Response Responses Response

General Topics: Pretest 27 1 27 0.25 6.75

General Topics: Screener 10,000 1 10,000 0.02 200

General Topics: Survey 3,000 1 3,000 0.25 750

Dietary Guidelines Supplement:

Screener 4,000 1 4,000 0.02 80

Dietary Guidelines Supplement:

Survey 1,200 1 1,200 0.22 264

Total 1,300.75
1There are no capital costs or operating and maintenance costs associated with this collection of information.

FDA has based its estimate of the
number of respondents and the burden
hours per response on its experience
with the Health and Diet Survey over
the past 3 years. The agency will use a
screener to select an eligible adult
respondent in each household to
participate in the survey. For the Health
and Diet Survey—General Topics data
collection activity a total of 3,000 adults
in the 50 states and the District of
Columbia will be interviewed by
telephone. We estimate that it will take
a respondent 1.2 minutes (0.02 hours) to
complete the screening questions and 15
minutes (0.25 hours) to complete the
entire survey. Prior to the
administration of the survey, the agency
plans to conduct a pretest to identify
mstockstill on PROD1PC66 with NOTICES
GuidelinesSupplement data collection
activity a total of 1,200 adults in the 50
states and the District of Columbia will
be interviewed by telephone. We
estimate that it will take a respondent
1.2 minutes (0.02 hours) to complete the
screening questions and 13.2 minutes
(0.22 hours) to complete the entire
survey. Target sample size of the
combined data collection is 4,200
respondents who complete the survey.
Dated: December 7, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–24123 Filed 12–12–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Quality System Regulation Educational
Forum on Design Controls; Public
Workshop; Amendment of Notice
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of public
workshop entitled ‘‘Quality System
Regulation Educational Forum on
Design Controls.’’ This workshop was
announced in the Federal Register of

and resolve potential problems. The October 11, 2007 (72 FR 57951). The
pretest will be conducted with 27 amendment is made to reflect a change
participants; we estimate that it will in the Location portion of the document.
take a respondent 15 minutes (0.25 There are no other changes.
hours) to complete the pretest. For the FOR FURTHER INFORMATION CONTACT:
Health and Diet Survey—Dietary David Arvelo, Food and Drug

VerDate Aug<31>2005 17:10 Dec 12, 2007 Jkt 214001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1
 70874 Federal Register / Vol. 72, No. 239 / Thursday, December 13, 2007 / Notices
Administration, 4040 North Central
Expressway, suite 900, Dallas, TX
75204, 214–253–4952, FAX: 214–253–
4970, e-mail: david.arvelo@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of October 11, 2007 (72
FR 57951), FDA announced that a
public workshop entitled ‘‘Quality
System Regulation Educational Forum
on Design Controls’’ would be held on
Friday, April 4, 2008. On page 57951, in
the second column, the Location portion
of the document is amended to read as
follows:
Location: The public workshop will
be held at the Adam’s Mark Hotel
Dallas, 400 North Olive St., Dallas, TX
75201, 214–922–8000. Directions to the
facility and additional information are
available at the FDA Medical Device
Industry Coalition Web site at http://
www.fmdic.org/.
Dated: December 7, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–24144 Filed 12–12–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Operations
and Technical Support at the NCI-Frederick.
Date: January 7, 2008.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate contract
mstockstill on PROD1PC66 with NOTICES
proposals.
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Lalita D. Palekar, PhD.
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
VerDate Aug<31>2005 17:10 Dec 12, 2007 Jkt 214001
Institute, 6116 Executive Blvd., Bethesda,
MD 20892–7405, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
G–Education.
Date: February 12–13, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington Silver
Spring, 8777 Georgia Ave., Silver Spring, MD
20910.
Contact Person: Sonya Roberson, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8109,
Bethesda, MD 20892, 301–594–1182,
robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, R25(E)
Special Emphasis Panel (SEP).
Date: February 12, 2008.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington Silver
Spring, 8777 Georgia Ave., Silver Spring, MD
20910.
Contact Person: Lynn M. Amende, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard Room
8105 Bethesda, MD 20892–8328, 301–451–
4759, amendel@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research, 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 4, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6034 Filed 12–12–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering, NACBIB January 2008.
Date: January 25, 2008.
Open: 8:30 a.m. to 1 p.m.
Agenda: Report from the Institute Director
and other Institute staff and presentations of
working group reports.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Closed: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD,
Director, National Institute of Biomedical
Imaging and Bioengineering, 6701
Democracy Blvd., Room 241, Bethesda, MD
20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: http://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
Dated: December 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6031 Filed 12–12–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute On Aging; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
13DEN1